Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Mersana Therapeutics, Inc. | SVP, Chief Medical Officer | Common Stock | 30.8K | $83.5K | $2.71 | Jan 17, 2023 | Direct |
Mersana Therapeutics, Inc. | SVP, Chief Medical Officer | Restricted stock unit | 21.2K | $57.6K | $2.71 | Jan 14, 2023 | Direct |
Mersana Therapeutics, Inc. | SVP, Chief Medical Officer | Stock option (right to buy) | 218K | Jan 13, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MRSN | Mersana Therapeutics, Inc. | Jan 13, 2023 | 5 | -$12.7K | 4 | Jan 18, 2023 | SVP, Chief Medical Officer |
MRSN | Mersana Therapeutics, Inc. | Nov 30, 2022 | 3 | -$36.4K | 4 | Dec 2, 2022 | Chief Medical Officer |
MRSN | Mersana Therapeutics, Inc. | Jan 14, 2022 | 2 | $0 | 4 | Jan 19, 2022 | Chief Medical Officer |
MRSN | Mersana Therapeutics, Inc. | Nov 30, 2021 | 3 | -$37.6K | 4 | Dec 2, 2021 | Chief Medical Officer |